MY
Healthcare & Life Sciences
Myrtelle
United States
Myrtelle is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About Myrtelle
Myrtelle is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Myrtelle develops gene therapies that target oligodendrocytes to treat myelin disorders and neurodegenerative diseases, with a lead candidate for Canavan's disease that has received FDA Orphan Drug, Rare Pediatric Disease, and Fast Track designations.
Explore Myrtelle's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.